BioSpace News Archive

PolarityTE Provides Update on Investigational New Drug Application

PolarityTE, Inc. today provided an update regarding its Investigational New Drug Application (IND) for SkinTE® with a proposed indication for chronic cutaneous ulcers submitted to the Food and Drug Administration (FDA) in July 2021

October 7, 2021
·
3 min read
Genetown

AffyImmune Therapeutics Announces $30M Series A+ Financing from ORI Capital

AffyImmune Therapeutics, Inc announced today the close of a $30 million Series A+ funding by ORI Capital (ORI).

October 7, 2021
·
3 min read
Genetown

iSpecimen Expands Global Biospecimen Supplier Network and Access to Human Biospecimens Needed to Help Accelerate Development of Liquid Biopsies

iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens (“iSpecimen” or the “Company”), today announced it is expanding its human biospecimen supplier network to offer increasingly comprehensive selections of whole blood, plasma and other biofluids to help accelerate the development of liquid biopsies.

October 7, 2021
·
4 min read
FDA

Venclose MAVEN Earns FDA Clearance to Treat Incompetent Perforator Veins

Venclose Inc. today announced FDA 510(k) clearance for Venclose Maven

October 7, 2021
·
3 min read
Drug Development

Inhalon Doses First Patient in Phase 1 Study of Inhaled IN-006 to Treat COVID-19

Inhalon Biopharma, Inc. today announced that the first patient has been dosed in a Phase 1 safety and tolerability study of IN-006 in healthy volunteers.

October 7, 2021
·
4 min read
Biotech Beach

Boundless Bio Presents Data on Extrachromosomal DNA (ecDNA) Driven Resistance to KRASG12C Inhibitors at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics 2021

Boundless Bio Presents Data on Extrachromosomal DNA (ecDNA) Driven Resistance to KRAS G12C Inhibitors at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics 2021

October 7, 2021
·
5 min read
Business

Seagen to Host Conference Call and Webcast Discussion of Third Quarter 2021 Financial Results on October 28, 2021

Seagen Inc. (Nasdaq: SGEN) today announced that it will report its third quarter 2021 financial results on Thursday, October 28, 2021 after the close of U.S. financial markets.

October 7, 2021
·
1 min read
Business

Atalanta Therapeutics Strengthens Leadership Team with Key Appointments in R&D and Corporate Development

Atalanta Therapeutics today announced the expansion of its leadership team with three new appointments: Morgan Molloy as chief corporate development officer; Stefan McDonough as vice president, head of neuroscience; and Garth Kinberger as vice president of chemistry.

October 7, 2021
·
3 min read
Biotech Bay

Blade Therapeutics Announces Publication of Preclinical Evidence Supporting Neuroprotective Effects of Proprietary Calpain Inhibitor in a Rare Inherited Neurodegenerative Disease

Blade Therapeutics, Inc. today announced peer-reviewed publication of preclinical study data supporting the neuroprotective effects of inhibiting dimeric calpains in spinocerebellar ataxia type-3 (SCA3).

October 7, 2021
·
5 min read
Business

MD Anderson and Schrödinger Announce Strategic Research Collaboration to Accelerate Development of WEE1 Program

The University of Texas MD Anderson Cancer Center and Schrödinger, Inc. today announced a two-year strategic research collaboration focused on accelerating and optimizing the development of Schrödinger’s WEE1 inhibitor program, an investigational therapeutic approach designed to target the WEE1 kinase.

October 7, 2021
·
7 min read